Clinical complications among patients with sickle cell disease with recurrent vaso-occlusive crises in Germany

被引：0
|
作者：
Tuzin, P. [1 ]
Udeze, C. [2 ]
Kunzweiler, C. [2 ]
Li, N. [2 ]
Baldwin, J. [2 ]
Barth, S. D. [3 ]
Vetter, C. [3 ]
Dombrowski, S. [3 ]
Georgiadou-Schmidt, E. [4 ]
Meisel, R. [5 ]
机构：
[1] Vertex Pharmaceut, Munich, Germany
[2] Vertex Pharmaceut Inc, Boston, MA USA
[3] IQVIA, Frankfurt, Germany
[4] Team Gesundheit Gesell Gesundheitsmanagement mbH, Essen, Germany
[5] Heinrich Heine Univ, Klin Padiat Onkol Hamatol & Klin Immunol, Dusseldorf, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2023年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1070
引用
收藏
页码：300 / 301
页数：2
相关论文
共 50 条
  • [41] BARRIERS TO IMPROVING ANALGESIA FOR VASO-OCCLUSIVE PAIN CRISES IN PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE
    Allewelt, Heather
    Saricicek, Jessica
    Patel, Sachit
    Rothman, Jennifer
    PEDIATRIC BLOOD & CANCER, 2015, 62 : 40 - 40
  • [42] Frequent Vaso-occlusive Crises Alter Brain Network Connectivity in Patients with Sickle Cell Disease
    Ichesco, Eric
    Pucka, Andrew Q.
    Harris, Richard E.
    Wang, Ying
    JOURNAL OF PAIN, 2024, 25 (04): : 47 - 47
  • [43] PROPHYLAXIS OF SICKLE-CELL VASO-OCCLUSIVE CRISES WITH PIRACETAM
    SONNET, J
    GINI, EK
    CORNU, G
    ANNALES DE LA SOCIETE BELGE DE MEDECINE TROPICALE, 1985, 65 (01): : 77 - 84
  • [44] THE RELATIONSHIP BETWEEN VASO-OCCLUSIVE CRISES AND WORK PRODUCTIVITY IMPAIRMENT IN PATIENTS WITH SICKLE CELL DISEASE
    Rizio, A.
    Bhor, M.
    Lin, X.
    White, M. K.
    Paulose, J.
    Nandal, S.
    Halloway, R., I
    Bronte-Hall, L.
    VALUE IN HEALTH, 2019, 22 : S345 - S345
  • [45] Elimination of vaso-occlusive crises after exagamglogene autotemcel in patients with severe Sickle Cell Disease
    Meisel, R.
    Frangoul, H.
    Locatelli, F.
    Sharma, A.
    Bhatia, M.
    Molinari, L.
    Wall, D.
    Liem, R.
    Telfer, P.
    Shah, A.
    Cavazzana, M.
    Corbacioglu, S.
    Rondelli, D.
    Dedeken, L.
    Lobitz, S.
    de Montalembert, M.
    Steinberg, M.
    Walters, M.
    Imren, S.
    Shi, D.
    Bower, L.
    Simard, C.
    Zhang, L.
    Morrow, P. K.
    Hobbs, B.
    Grupp, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 99 - 100
  • [46] Clinical Burden and Health Care Resource Utilization Associated With Managing Sickle Cell Disease With Recurrent Vaso-occlusive Crises in England
    Udeze, Chuka
    Ly, Nelly F.
    Ingleby, Fiona C.
    Fleming, Sophia D.
    Conner, Sarah C.
    Howard, Jo
    Li, Nanxin
    Shah, Farrukh
    CLINICAL THERAPEUTICS, 2025, 47 (01) : 29 - 36
  • [47] A randomized, controlled clinical trial of ketoprofen for sickle-cell disease vaso-occlusive crises in adults
    Bartolucci, Pablo
    El Murr, Tony
    Roudot-Thoraval, Francoise
    Habibi, Anoosha
    Santin, Aline
    Renaud, Bertrand
    Noël, Violaine
    Michel, Marc
    Bachir, Dora
    Galacteros, Frederic
    Godeau, Bertrand
    BLOOD, 2009, 114 (18) : 3742 - 3747
  • [48] Frequency of vaso-occlusive crises among patients with severe sickle cell disease receiving standard-of-care treatment
    Titievsky, Lina
    Manjelievskaia, Janna
    Ender, Katherine L.
    Shi, Daoyuan
    Lillehaugen, Timothy
    Beukelman, Timothy
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 85 - 85
  • [49] OPTIMIZATION OF PAIN MANAGEMENT STRATEGIES IN CHILDREN WITH SICKLE CELL DISEASE AND VASO-OCCLUSIVE CRISES
    LeBlanc, Dana
    Velez, Maria
    Gardner, Renee
    PEDIATRIC BLOOD & CANCER, 2015, 62 : 46 - 46
  • [50] Treatment of uncomplicated vaso-occlusive crises in children with sickle cell disease in a day hospital
    Raphael, Jean L.
    Kamdar, Aditi
    Beavers, M. Brooke
    Mahoney, Donald H.
    Mueller, Brigitta U.
    PEDIATRIC BLOOD & CANCER, 2008, 51 (01) : 82 - 85
12345